A detailed history of Benchmark Investment Advisors LLC transactions in Stryker Corp stock. As of the latest transaction made, Benchmark Investment Advisors LLC holds 613 shares of SYK stock, worth $239,155. This represents 0.16% of its overall portfolio holdings.

Number of Shares
613
Previous 613 -0.0%
Holding current value
$239,155
Previous $208,000 6.25%
% of portfolio
0.16%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$324.3 - $354.67 $324 - $354
1 Added 0.16%
613 $208,000
Q1 2024

May 15, 2024

SELL
$293.94 - $358.71 $92,297 - $112,634
-314 Reduced 33.91%
612 $219,000
Q4 2023

Feb 13, 2024

BUY
$253.85 - $299.46 $235,065 - $277,299
926 New
926 $277,000
Q2 2022

Aug 08, 2022

SELL
$194.09 - $276.37 $151,390 - $215,568
-780 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$245.33 - $277.77 $3,434 - $3,888
-14 Reduced 1.76%
780 $209,000
Q4 2021

Feb 16, 2022

BUY
$236.63 - $276.44 $187,884 - $219,493
794 New
794 $212,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $148B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Benchmark Investment Advisors LLC Portfolio

Follow Benchmark Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Benchmark Investment Advisors LLC with notifications on news.